Evidence map›Paper›PMID 39368561›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2024

Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis.

Anna K Whitehead, Zhangjie Wang, Rebecca-Joe Boustany, Romain R Vivès, Eric Lazartigues, Jian Liu, Robert W Siggins, Xinping Yue

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna K WhiteheadCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Zhangjie WangGlycan Therapeutics Corporation, Raleigh, NC, USA.
Rebecca-Joe BoustanyUniversity of Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Romain R VivèsUniversity of Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Eric LazartiguesCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
Robert W SigginsDepartment of Physiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Xinping YueCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA. Electronic address: xyue@lsuhsc.edu.

Funding

Development of analytical methods for glycosaminoglycans from biological sourcesR44GM142304 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI WANG, ZHANGJIE · 2022 to 2023
$2.0M
E-cigarette Inhalation and Cardiopulmonary DysfunctionF30HL160071 · NHLBI · LSU HEALTH SCIENCES CENTER · PI WHITEHEAD, ANNA KATHRYN · 2021 to 2025
$131k
NHLBI NIH HHS F30 HL160071NIGMS NIH HHS R44 GM142304
6 · The paper itself

Abstract

The heparan sulfate (HS) 6-O-endosulfatases or the Sulfs (Sulf1 and Sulf2) are the only known enzymes that can modify HS sulfation status extracellularly and have been shown to regulate diverse biological processes. The role of the Sulfs in bone marrow (BM) hematopoiesis is not known. In this study, we generated a novel mouse line with myeloid-specific deletion of the Sulfs by crossing Sulf1/2 double floxed mice with the LysM-cre line. The LysM-Sulf knockout (KO) male mice exhibited age-dependent expansion of hematopoietic stem cells and the granulocyte-monocyte lineages in the BM, whereas common lymphoid progenitors and B lymphocyte populations were significantly reduced. Although megakaryocytic and erythroid progenitors were not reduced in the BM, the LysM-Sulf KO males suffered age-dependent reduction of red blood cells (RBCs) and platelets in the peripheral blood, suggesting that the production of RBCs and platelets was arrested at later stages. In addition, LysM-Sulf KO males displayed progressive splenomegaly with extramedullary hematopoiesis. Compared to males, LysM-Sulf KO females exhibited a much-reduced phenotype, and ovariectomy had little effect. Mechanistically, reduced TGF-β/Smad2 but enhanced p53/p21 signaling were observed in male but not female LysM-Sulf KO mice. Finally, HS disaccharide analysis via LC-MS/MS revealed increased HS 6-O-sulfation in the BM from both male and female LysM-Sulf KO mice, however, the distribution of 6-O-sulfated motifs were different between the sexes with compensatory increase in Sulf1 expression observed only in LysM-Sulf KO females. In conclusion, our study reveals that myeloid deficiency of the Sulfs leads to multilineage abnormalities in BM hematopoiesis in an age- and sex-dependent manner.

Indexed as

HematopoiesisMice, KnockoutSulfotransferasesAnimalsBone MarrowFemaleHematopoietic Stem CellsHeparan SulfateMaleMiceMyeloid CellsSignal TransductionSulfatasesHeparan SulfateSulf1 protein, mouseSulf2 protein, mouseSulfatasesSulfotransferasesBone marrowHematopoiesisHeparan sulfateSulf1Sulf2

Identifiers

PMID39368561
PMCPMC11585435

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.